Commentary: Experimental Mouse Models of Invasive Candidiasis Caused by Candida auris and Other Medically Important Candida Species
- PMID: 35847345
- PMCID: PMC9286494
- DOI: 10.33696/immunology.4.130
Commentary: Experimental Mouse Models of Invasive Candidiasis Caused by Candida auris and Other Medically Important Candida Species
Abstract
The study ""Experimental Mouse Models of Disseminated Candida auris Infection" provides the first insight into the critical role of C5 in the host antimicrobial defense to disseminated candidiasis caused by C. auris. This study also establishes an inbred A/J mouse model of systemic C. auris infection without drug-induced immunosuppression. C. auris has become the first fungal pathogen causing global public health threat due to its multidrug resistance (MDR) and persistence in hospital and nursing home settings. Currently, as compared to C. albicans, very limited animal models are available to study the progression of non-albicans Candida (NAC) species including C. auris. We have successfully established immunosuppressed C57BL/6, BALB/c and A/J murine models of disseminated candidiasis caused by five clinically significant Candida species: C. albicans, C. glabrata, C. tropicalis, C. parapsilosis and C. auris. Here we also report updated progress of some important mouse models for C. auris infection in the field. These valuable mouse models can be used for the assessment of antifungal drugs, evaluation of potential vaccines and monoclonal antibodies (mAbs) to protect before and after candidiasis, and comparison of pathogenicity of different Candida species.
Similar articles
-
Experimental Mouse Models of Disseminated Candida auris Infection.mSphere. 2019 Sep 4;4(5):e00339-19. doi: 10.1128/mSphere.00339-19. mSphere. 2019. PMID: 31484737 Free PMC article.
-
Effects of immune suppression in murine models of disseminated Candida glabrata and Candida tropicalis infection and utility of a synthetic peptide vaccine.Med Mycol. 2019 Aug 1;57(6):745-756. doi: 10.1093/mmy/myy122. Med Mycol. 2019. PMID: 30521033 Free PMC article.
-
Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis.mSphere. 2023 Feb 21;8(1):e0058422. doi: 10.1128/msphere.00584-22. Epub 2023 Jan 23. mSphere. 2023. PMID: 36688668 Free PMC article.
-
The continuous changes in the aetiology and epidemiology of invasive candidiasis: from familiar Candida albicans to multiresistant Candida auris.Int Microbiol. 2018 Sep;21(3):107-119. doi: 10.1007/s10123-018-0014-1. Epub 2018 Jul 6. Int Microbiol. 2018. PMID: 30810955 Review.
-
Candida auris: Epidemiology, biology, antifungal resistance, and virulence.PLoS Pathog. 2020 Oct 22;16(10):e1008921. doi: 10.1371/journal.ppat.1008921. eCollection 2020 Oct. PLoS Pathog. 2020. PMID: 33091071 Free PMC article. Review.
Cited by
-
Comprehensive Overview of Candida auris: An Emerging Multidrug-Resistant Fungal Pathogen.J Microbiol Biotechnol. 2024 Jul 28;34(7):1365-1375. doi: 10.4014/jmb.2404.04040. Epub 2024 Jun 15. J Microbiol Biotechnol. 2024. PMID: 38881183 Free PMC article. Review.
-
Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis.mSphere. 2024 Jul 30;9(7):e0018924. doi: 10.1128/msphere.00189-24. Epub 2024 Jun 21. mSphere. 2024. PMID: 38904363 Free PMC article.
References
-
- Dimopoulos G, Ntziora F, Rachiotis G, Armaganidis A, Falagas ME. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesthesia & Analgesia. 2008. Feb 1;106(2):523–9. - PubMed
-
- Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, Powderly W, et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clinical Infectious Diseases. 2003. Sep 1;37(5):634–43. - PubMed
-
- Viudes A, Peman J, Canton E, Ubeda P, Lopez-Ribot J, Gobernado M. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. European Journal of Clinical Microbiology and Infectious Diseases. 2002. Nov;21(11):767–74. - PubMed
-
- Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. Journal of Hospital Infection. 2002. Apr 1;50(4):243–60. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous